Hitoshi ONO
Papers
1
Total Citations
7
H-Index
1
About
Hitoshi Ono is a leading figure in stereotactic ablative body radiotherapy (SABR), with a focused expertise in treating metastatic lung tumors using advanced robotic radiosurgery. His major contribution lies in pioneering a central high-dose SABR technique with the CyberKnife system—a robotically-positioned linear accelerator that delivers real-time image-guided radiation from hundreds of directions. This approach achieves exceptionally steep dose gradients, enabling precise dose escalation to the tumor core while sparing surrounding healthy tissue. Ono’s 2023 study on this method, which has already garnered 7 citations, demonstrates improved local control for metastatic lung lesions, offering a non-invasive alternative for patients with limited treatment options. His work addresses a critical challenge in radiation oncology: balancing tumor eradication with toxicity minimization. By optimizing CyberKnife’s unique capabilities, Ono has advanced the field of oligometastatic disease management, providing a framework for safer, more effective SABR. His research continues to shape clinical protocols, with ongoing impact on patient outcomes and the broader adoption of robotic radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1